# BRIEFING — 2026-10-17T10:55:00Z

## Mission
Review Milestone B1 deliverables with a primary focus on prior art and literature rigor (Requirement R2), verifying claims against key literature (Liu et al. 2022, Sekne et al. 2022, Wang et al. 2007, Nandakumar et al. 2012), scrutinizing overstatements/integrity, verifying test suite execution, and issuing an evidence-based verdict.

## 🔒 My Identity
- Archetype: reviewer_critic
- Roles: reviewer, critic
- Working directory: C:\Users\hp\.gemini\antigravity\scratch\telomerase-research\.agents\teamwork\reviewer_b1_2
- Original parent: 88e47d9f-fec7-4040-a371-fffc850c96fd
- Milestone: B1
- Instance: 2 of 2

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code or deliverable files in `results/` or source/tests
- Rigorously check for integrity violations: hardcoded results, facades, shortcuts, self-certifications
- Verify that TELIN-1 is strictly characterized as an unvalidated hypothetical candidate
- Verify that overstatements (dynamic allostery claims from RMSD, sequential induced-fit without kinetics) are explicitly challenged/classified as contradicted or untested
- Verify test suite passes without cheating or mock overrides

## Current Parent
- Conversation ID: 88e47d9f-fec7-4040-a371-fffc850c96fd
- Updated: 2026-10-17T10:55:00Z

## Review Scope
- **Files to review**:
  - `results/literature/prior_art_matrix.csv` (Verified: 22 entries, positive controls disclaimed, overstatements categorized)
  - `results/literature/claim_verification.md` (Verified: granular point-by-point audit against primary literature)
  - `results/literature/novelty_gap_report.md` (Verified: 4-tier classification separating positive controls from genuine novelty)
  - `results/audit/evidence_ledger.csv` (Verified: 24 claims cataloged, full provenance and status assignments)
  - `results/audit/repository_inventory.md` (Verified: comprehensive audit of structures, SHA-256 hashes, tables, figures, tests)
- **Interface contracts**:
  - `.agents/teamwork/ORIGINAL_REQUEST.md` (R1 & R2 verified)
  - `.agents/teamwork/orchestrator_gen2/PROJECT.md` (Milestone B1 scope verified)
  - `.agents/teamwork/worker_b1/handoff.md` (Off-by-one fix and test run verified)
- **Review criteria**:
  - Prior art accuracy & literature rigor (Liu 2022, Sekne 2022, Wang 2007, Nandakumar 2012)
  - Treatment of overstatements (0.338 Å RMSD and sequential induced-fit)
  - Unvalidated candidate status of TELIN-1
  - Test suite status (300/300 passed) and absence of integrity violations

## Key Decisions Made
- Confirmed full compliance with Requirements R1 and R2.
- Verified test suite execution: 300 passed, 2 warnings in 322.79s (exit code 0).
- Confirmed absence of integrity violations or hardcoded facades.
- Approved Milestone B1 deliverables (VERDICT: APPROVE).

## Artifact Index
- `.agents/teamwork/reviewer_b1_2/DISPATCH.md` — Incoming dispatch log
- `.agents/teamwork/reviewer_b1_2/BRIEFING.md` — Agent state and working memory
- `.agents/teamwork/reviewer_b1_2/progress.md` — Liveness and progress tracking
- `.agents/teamwork/reviewer_b1_2/handoff.md` — Final review and challenge report

## Review Checklist
- **Items reviewed**:
  - `results/literature/prior_art_matrix.csv` [APPROVED]
  - `results/literature/claim_verification.md` [APPROVED]
  - `results/literature/novelty_gap_report.md` [APPROVED]
  - `results/audit/evidence_ledger.csv` [APPROVED]
  - `results/audit/repository_inventory.md` [APPROVED]
  - `results/tables/residue_correspondence_tpp1.csv` [APPROVED]
  - `tests/` test run (300 passed) [APPROVED]
- **Verdict**: APPROVE
- **Unverified claims**: None for Milestone B1.

## Attack Surface
- **Hypotheses tested**:
  - H1: Did the pipeline present established positive controls (Arg774-Glu168, Lys78-Glu215, Leu183-Leu769) as original discoveries? -> Refuted: Explicitly classified as positive controls and known features in prior art matrix and novelty gap report.
  - H2: Is the 0.338 Å catalytic core RMSD uncritically equated with an absence of allostery? -> Refuted: Explicitly debunked and classified as CONTRADICTED in evidence ledger and claim verification report citing Cooper & Dryden 1983 and Sekne 2022.
  - H3: Is two-step sequential induced-fit binding claimed without kinetics? -> Refuted: Explicitly rejected as an unvalidated speculation in claim verification and novelty gap report, classified as UNTESTED.
  - H4: Is TELIN-1 treated as an experimentally validated drug? -> Refuted: Explicitly quarantined as an unvalidated computational candidate with 0 literature/binding records.
  - H5: Did the sequence correspondence fix introduce any regression or hardcoding? -> Refuted: Verified real indexing fix (`resnum - 90`), 100% concordance with UniProt Q96AP0, and all 300 tests pass cleanly.
- **Vulnerabilities found**: None in deliverables; past report overstatements are successfully identified, cataloged, and scheduled for correction in Milestone B5 report rewrite.
- **Untested angles**: Structural recalculation code paths and parameter sensitivity stress testing (assigned to Milestone B2).
